Abstract
BALB/c mice were injected intravenously with three different monoclonal antibodies (mAbs) specific for complement receptor 1 (CR1). Two of the mAbs crossreacted with CR2. 24 h later, the mice were immunized with horse erythrocytes or keyhole limpet hemocyanin (KLH), and the primary antibody response was measured. One of the anti-CR antibodies, 7G6, suppressed greater than 99% of the direct plaque-forming cell response against horse red blood cells (HRBC). The same antibody markedly suppressed the serum antibody responses to both HRBC and KLH. To be optimally suppressive, the mAb had to be injected before suboptimal concentrations of antigen. The other two complement receptor-specific antibodies had very moderate, if any, effects on the antibody response. 7G6 was able to downregulate CR1 and CR2 on the surface of B cells and, in addition, to inhibit rosette formation with C3d-coated sheep erythrocytes (EC3d). One of the antibodies with a weak effect downregulated only CR1. The other downregulated both CR1 and CR2, although not as efficiently as 7G6, and was unable to inhibit EC3d rosette formation. We conclude that the reason 7G6 is outstanding in its suppressive capacity is that it is the only mAb tested that functionally blocks CR2. The data suggest that CR2 is of crucial importance in the initiation of a normal antibody response to physiological concentrations of antigen.
Full Text
The Full Text of this article is available as a PDF (364.1 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Böttger E. C., Hoffmann T., Metzger S., Hadding U., Bitter-Suermann D. The role and mechanism of cobra venom factor-induced suppression of the humoral immune response in guinea pigs. J Immunol. 1986 Aug 15;137(4):1280–1285. [PubMed] [Google Scholar]
- Enriquez-Rincon F., Klaus G. G. Follicular trapping of hapten-erythrocyte-antibody complexes in mouse spleen. Immunology. 1984 May;52(1):107–116. [PMC free article] [PubMed] [Google Scholar]
- Erdei A., Melchers F., Schulz T., Dierich M. The action of human C3 in soluble or cross-linked form with resting and activated murine B lymphocytes. Eur J Immunol. 1985 Feb;15(2):184–188. doi: 10.1002/eji.1830150214. [DOI] [PubMed] [Google Scholar]
- Heyman B., Holmquist G., Borwell P., Heyman U. An enzyme-linked immunosorbent assay for measuring anti-sheep erythrocyte antibodies. J Immunol Methods. 1984 Mar 30;68(1-2):193–204. doi: 10.1016/0022-1759(84)90150-9. [DOI] [PubMed] [Google Scholar]
- Heyman B., Nose M., Weigle W. O. Carbohydrate chains on IgG2b: a requirement for efficient feedback immunosuppression. J Immunol. 1985 Jun;134(6):4018–4023. [PubMed] [Google Scholar]
- Heyman B., Pilström L., Shulman M. J. Complement activation is required for IgM-mediated enhancement of the antibody response. J Exp Med. 1988 Jun 1;167(6):1999–2004. doi: 10.1084/jem.167.6.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jackson C. G., Ochs H. D., Wedgwood R. J. Immune response of a patient with deficiency of the fourth component of complement and systemic lupus erythematosus. N Engl J Med. 1979 May 17;300(20):1124–1129. doi: 10.1056/NEJM197905173002002. [DOI] [PubMed] [Google Scholar]
- Kinoshita T., Takeda J., Hong K., Kozono H., Sakai H., Inoue K. Monoclonal antibodies to mouse complement receptor type 1 (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative. J Immunol. 1988 May 1;140(9):3066–3072. [PubMed] [Google Scholar]
- Klaus G. G. The generation of memory cells. II. Generation of B memory cells with preformed antigen-antibody complexes. Immunology. 1978 Apr;34(4):643–652. [PMC free article] [PubMed] [Google Scholar]
- Matsuda T., Martinelli G. P., Osler A. G. Studies on immunosuppression by cobra venom factor. II. On responses to DNP-Ficoll and DNP-Polyacrylamide. J Immunol. 1978 Nov;121(5):2048–2051. [PubMed] [Google Scholar]
- Melchers F., Erdei A., Schulz T., Dierich M. P. Growth control of activated, synchronized murine B cells by the C3d fragment of human complement. Nature. 1985 Sep 19;317(6034):264–267. doi: 10.1038/317264a0. [DOI] [PubMed] [Google Scholar]
- Nemerow G. R., McNaughton M. E., Cooper N. R. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes. J Immunol. 1985 Nov;135(5):3068–3073. [PubMed] [Google Scholar]
- O'Neil K. M., Ochs H. D., Heller S. R., Cork L. C., Morris J. M., Winkelstein J. A. Role of C3 in humoral immunity. Defective antibody production in C3-deficient dogs. J Immunol. 1988 Mar 15;140(6):1939–1945. [PubMed] [Google Scholar]
- Ochs H. D., Wedgwood R. J., Frank M. M., Heller S. R., Hosea S. W. The role of complement in the induction of antibody responses. Clin Exp Immunol. 1983 Jul;53(1):208–216. [PMC free article] [PubMed] [Google Scholar]
- Papamichail M., Gutierrez C., Embling P., Johnson P., Holborow E. J., Pepys M. B. Complement dependence of localisation of aggregated IgG in germinal centres. Scand J Immunol. 1975;4(4):343–347. doi: 10.1111/j.1365-3083.1975.tb02635.x. [DOI] [PubMed] [Google Scholar]
- Pepys M. B. Role of complement in induction of antibody production in vivo. Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses. J Exp Med. 1974 Jul 1;140(1):126–145. doi: 10.1084/jem.140.1.126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Romball C. G., Ulevitch R. J., Weigle W. O. Role of C3 in the regulation of a splenic PFC response in rabbits. J Immunol. 1980 Jan;124(1):151–155. [PubMed] [Google Scholar]